<p>Cells were pre-treated for 90 min with different concentrations of UA (70,100, 120 μM) and then treated with LPS (1 μg/ml) for 20 min. Nuclear extracts were prepared as described in materials and methods section and determined for western blotting of NF-κB and Phospho-IKKα/β proteins using specific antibodies. GAPDH served as both an internal loading control and as a nuclear fractionation control. Density ratios versus GAPDH were determined by densitometry. Results are representative of three independent experiments.</p
<p>(A) CRT-MG cells stably expressing pEGFP or pEGFP-UBB<sup>+1</sup> were treated with TNF-α (10 µg...
<p>(A) 786-0 cells have constitutively active NF-κB. WT MEFs or 786-O cells were induced with DTT fo...
<p>(A) Don Q cells were treated without (control) or with CpPLC at different times (3, 5 or 7 hours)...
<p>Cells were pre-treated for 90 min with different concentrations of CA (20, 50, 70 μM) and then tr...
<p>A549 cells were transfected with 2 µg of either pORF3-EGFP (ORF3) or pEGFP-N1 empty vector (GFP),...
(a–b) RAW264.7 cells were treated simultaneously with indicated concentrations of GYY4137 and LPS. (...
<p>A western blot assay to detect cytosolic inhibitor of κB (IκB), nuclear total and phosphorylated ...
<p>A. The cells were incubated with 0, 10, 50, 250, and 1000 ng/ml Ang for 2 h. The proteins of phos...
<p>(A) RAW264.7 cells pretreated with or without complex <b>5</b> for 4 h were treated with LPS for ...
<p><b>A</b>) Naïve and resistant RAW 264.7 cells (ResRAW) were exposed to PAO1 (MOI 10) or to LPS (1...
<p>SK-HEP1 liver cancer cells were treated with (at 0.5 mg/ml) or without AcFBE for 2 or 4 hrs. Immu...
A) Western blot assays performed on U87 cell lysates in the control condition and after treatment wi...
<p><b>(A)</b> Western blot analysis of soluble (S) and insoluble (IS) NF-κB p65, IKKα and IKKβ prote...
(a–c) RAW264.7 cells were initially treated with IKK-inhibitor Bay11-7042 (15μM) or PI3k inhibitor L...
<p>(A) Western blot analysis to see the nuclear and cytosolic expression of NF-κB in MDA-MB 231 cell...
<p>(A) CRT-MG cells stably expressing pEGFP or pEGFP-UBB<sup>+1</sup> were treated with TNF-α (10 µg...
<p>(A) 786-0 cells have constitutively active NF-κB. WT MEFs or 786-O cells were induced with DTT fo...
<p>(A) Don Q cells were treated without (control) or with CpPLC at different times (3, 5 or 7 hours)...
<p>Cells were pre-treated for 90 min with different concentrations of CA (20, 50, 70 μM) and then tr...
<p>A549 cells were transfected with 2 µg of either pORF3-EGFP (ORF3) or pEGFP-N1 empty vector (GFP),...
(a–b) RAW264.7 cells were treated simultaneously with indicated concentrations of GYY4137 and LPS. (...
<p>A western blot assay to detect cytosolic inhibitor of κB (IκB), nuclear total and phosphorylated ...
<p>A. The cells were incubated with 0, 10, 50, 250, and 1000 ng/ml Ang for 2 h. The proteins of phos...
<p>(A) RAW264.7 cells pretreated with or without complex <b>5</b> for 4 h were treated with LPS for ...
<p><b>A</b>) Naïve and resistant RAW 264.7 cells (ResRAW) were exposed to PAO1 (MOI 10) or to LPS (1...
<p>SK-HEP1 liver cancer cells were treated with (at 0.5 mg/ml) or without AcFBE for 2 or 4 hrs. Immu...
A) Western blot assays performed on U87 cell lysates in the control condition and after treatment wi...
<p><b>(A)</b> Western blot analysis of soluble (S) and insoluble (IS) NF-κB p65, IKKα and IKKβ prote...
(a–c) RAW264.7 cells were initially treated with IKK-inhibitor Bay11-7042 (15μM) or PI3k inhibitor L...
<p>(A) Western blot analysis to see the nuclear and cytosolic expression of NF-κB in MDA-MB 231 cell...
<p>(A) CRT-MG cells stably expressing pEGFP or pEGFP-UBB<sup>+1</sup> were treated with TNF-α (10 µg...
<p>(A) 786-0 cells have constitutively active NF-κB. WT MEFs or 786-O cells were induced with DTT fo...
<p>(A) Don Q cells were treated without (control) or with CpPLC at different times (3, 5 or 7 hours)...